ストックスクリーナーアプリを入手
3.46
10.19%
0.32
前日終値:
$3.14
開ける：
$3.14
24時間の取引高:
2,238
Relative Volume:
0.04
時価総額：
$4.87M
収益：
$59.11M
当期純損益:
$-33.38M
株価収益率:
-0.0193
EPS:
-178.995
ネットキャッシュフロー:
$-26.04M
1週間 パフォーマンス:
+2.37%
1か月 パフォーマンス:
-21.90%
6か月 パフォーマンス:
-72.44%
1年 パフォーマンス:
-88.06%
1日の値動き範囲:
$3.1006
$3.38
1週間の範囲:
$2.85
$3.58
52週間の値動き範囲:
$2.5211
$38.52
Dna X Inc Stock (SONM) Company Profile
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
3.27 | 4.42M | 59.11M | -33.38M | -26.04M | -179.00 |
MSFT
Microsoft Corporation
|
394.24 | 2.75T | 305.45B | 119.26B | 77.41B | 15.98 |
ORCL
Oracle Corp
|
162.88 | 397.15B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
136.52 | 306.28B | 4.48B | 1.63B | 2.10B | 0.6328 |
CRWD
Crowdstrike Holdings Inc
|
399.58 | 96.12B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
419.62 | 75.14B | 8.00B | 1.10B | 2.28B | 6.4708 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-10-31 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-07-18 | 開始されました | B. Riley FBR | Buy |
| 2019-07-09 | アップグレード | National Securities | Neutral → Buy |
| 2019-06-10 | 開始されました | National Securities | Neutral |
| 2019-06-04 | 開始されました | Lake Street | Buy |
| 2019-06-04 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Dna X Inc (SONM) 最新ニュース
Earnings Report: Will Applied DNA Sciences Inc outperform its industry peersTrade Entry Report & Smart Allocation Stock Reports - baoquankhu1.vn
SONM Stock Price, Quote & Chart | DNA X INC (NASDAQ:SONM) - ChartMill
Restriction-enzyme DNA fingerprinting method explained - Britannica
NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test - The Manila Times
DNA X : News Release - marketscreener.com
Non-controlling/minority interest of DNA X, Inc. – MUN:J6P - TradingView
Power DNA x Lain: Okori enerugî (Music Video 2017)News - IMDb
How DNA's Double Helix Structure Was Discovered - Britannica
DNA X, Inc. delays 2025 annual filing - The Globe and Mail
Dna X Inc. Live Share Prices and Trades. SONM.US Live Streaming Share Prices. - London South East
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session - Benzinga
[NT 10-K] DNA X, Inc. SEC Filing - Stock Titan
Ansa Biotechnologies Appoints Matthias Arenskötter as Chief Operating Officer - Business Wire
12 Information Technology Stocks Moving In Monday's Intraday SessionAmplitech Group, Inc.Series A R - Benzinga
Feel Good Inc. X DNA. (Mashup) [1e740c] - Fathom Journal
DNA X (SONM) Surges 21.9% on Intraday Spike—What’s Behind the Volatility? - Bitget
The latest Star Wars Zero Company details tease Mass Effect DNA, hardcore turn-based tactics, permadeath, and new Clone Wars lore - Eurogamer.net
SONM Forecast, Price Target & Analyst Ratings | DNA X INC (NASDAQ:SONM) - ChartMill
Dna Holdings Venture Inc. Net Worth (2026) - GuruFocus
Illumina Inc.: Why This DNA Giant Just Got Way More Interesting for You - AD HOC NEWS
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
Equity in earnings of DNA X, Inc. – MUN:J6P - TradingView
Hitachi's DNA on Display at Its Birthplace Why the Company's Origin Park Matters as It Globalizes - 東洋経済オンライン
DNA Brands, Inc. (DNAX) Competitors - Meyka
SONM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 Earnings Call Transcript - insidermonkey.com
DNA X (NASDAQ: SONM) revises view of DNA X LLC acquisition - Stock Titan
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
How do XX and XY Chromosomes Determine Biological Sex? - Britannica
SONM SEC FilingsDNA X 10-K, 10-Q, 8-K Forms - Stock Titan
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors - Yahoo Finance Singapore
Major SONM holder DNA Holdings Venture reports 223,201 shares - Stock Titan
DNA Holdings takes 19.99% stake in DNA X, Inc. (SONM) with board rights - Stock Titan
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation - Stock Titan
cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis - Nature
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Feb. 13 Policy Watch: Bipartisan bills target DNA bioweapons, battery supply chain - Chemical & Engineering News
Leadership and Strategy Shift at DNA X Following Core Business Divestment - AD HOC NEWS
Sonim Technologies Names Mike Mulica Acting Chief Executive - TipRanks
DNA X, Inc. Appoints Mike Mulica as Acting CEO - TradingView — Track All Markets
DNAX stock jumps to $0.0001 on 09 Feb 2026 (PNK): liquidity and valuation in focus - Meyka
Nancy Guthrie’s blood was found on her porch, DNA testing confirms - WBAY
Sonim Technologies Sees Executive Departures and New Board Appointment - TipRanks
Leadership shake-up at DNA X (NASDAQ: SONM) as CEO exits and investor designee joins board - Stock Titan
GPT-5 lab runs 36,000 experiments, cuts protein costs 40% - Stock Titan
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price, News, Quote & History - Yahoo Finance
Why Ginkgo Bioworks Holdings, Inc. (DNA) Dipped More Than Broader Market Today - Yahoo Finance
Acurx patent backs new antibiotics for C. diff and MRSA - Stock Titan
Will Sonim Technologies Inc. stock outperform value stocksJuly 2025 Opening Moves & Weekly Stock Breakout Alerts - mfd.ru
DNA X Inc Share Price USD0.001 - Hargreaves Lansdown
Ginkgo Bioworks Holdings, Inc. (DNA) Declines More Than Market: Some Information for Investors - Yahoo Finance
Dna X Inc (SONM) 財務データ
収益
当期純利益
現金流量
EPS
2.59%
2.02%
大文字化:
|
ボリューム (24 時間):